Bio-Connect
Recombinant Yellow Fever Virus Envelope Protein were separated by 15% SDS-PAGE, and the membrane was blotted with Yellow Fever virus Envelope Protein antibody (GTX134024) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
Recombinant Yellow Fever Virus Envelope Protein were separated by 15% SDS-PAGE, and the membrane was blotted with Yellow Fever virus Envelope Protein antibody (GTX134024) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
Recombinant Yellow Fever Virus Envelope Protein were separated by 15% SDS-PAGE, and the membrane was blotted with Yellow Fever virus Envelope Protein antibody (GTX134024) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.

Yellow Fever virus Envelope Protein antibody

GTX134024
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Yellow Fever virus Envelope Protein antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1.25 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Virus
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Gao Z, Zhang L, Ma J, et al. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus. Antiviral Res. 2020,182:104907. doi: 10.1016/j.antiviral.2020.104907
    Read this paper
  • Garg H, Mehmetoglu-Gurbuz T, Joshi A. Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus. Sci Rep. 2020,10(1):4017. doi: 10.1038/s41598-020-61103-1
    Read this paper